Price
490.8
-2.1%52W Range
Market Cap
₹15,615.33 Cr
Traded: ₹5.32 Cr (0.03%) 0.0x
Free Float: ₹1,236.73 Cr (0.43% of FF traded)
Volume · 60D trend
1.08 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | +6.0% | +6.0% | +5.0% | -- | -- | Stable |
| Return | +13.0% | +3.0% | +23.0% | +30.0% | -- | Accelerating |
| Profit | +8.0% | -2.0% | -10.0% | -- | -31.0% | Decelerating |
| Sales | +26.0% | +16.0% | +21.0% | -- | +66.0% | Accelerating |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,437 | 1,485 | 965 | 650 | 861 | 913 | 462 | 493 | 841 | 783 | 403 | 440 | 702 | 713 | 416 | 429 |
| Expenses | 1,195 | 1,215 | 904 | 628 | 705 | 723 | 447 | 473 | 686 | 620 | 390 | 423 | 586 | 568 | 388 | 413 |
| Operating Profit | 242 | 270 | 61 | 23 | 156 | 190 | 15 | 20 | 155 | 162 | 13 | 17 | 116 | 145 | 28 | 16 |
| OPM % | 17.0% | 18.0% | 6.0% | 3.5% | 18.0% | 21.0% | 3.2% | 4.0% | 18.0% | 21.0% | 3.1% | 3.8% | 17.0% | 20.0% | 7.0% | 4.0% |
| Other Income | 4 | 1 | -6 | -33 | 3 | 1 | 4 | 10 | 5 | 4 | 3 | 4 | -12 | -6 | 1 | 1 |
| Interest | 26 | 39 | 41 | 16 | 2 | 4 | 3 | 1 | 4 | 6 | 6 | 6 | 5 | 5 | 4 | 3 |
| Depreciation | 57 | 55 | 56 | 25 | 11 | 13 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 7 | 6 | 6 |
| Profit Before Tax | 162 | 177 | -42 | -51 | 145 | 173 | 10 | 24 | 152 | 154 | 4 | 9 | 93 | 126 | 19 | 8 |
| Tax % | 27.0% | 9.0% | -4.0% | 4.0% | 12.0% | 1.0% | 37.0% | 12.0% | 3.0% | 3.0% | 92.0% | 31.0% | -18.0% | -15.0% | -1.0% | -4.0% |
| Net Profit | 119 | 162 | -40 | -53 | 128 | 172 | 6 | 21 | 148 | 150 | 0 | 6 | 110 | 145 | 20 | 8 |
| Exceptional Items | -- | 0 | -7 | -34 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | -14 | -7 | 0 | 0 |
| EPS (Rs) | 3.7 | 5.1 | -1.3 | -1.7 | 4.0 | 5.4 | 0.2 | 0.7 | 4.6 | 4.7 | 0.0 | 0.2 | 3.5 | 4.6 | 0.6 | 0.3 |
| Sales Growth (YoY) | 66.9% | 62.6% | 108.9% | 31.9% | 2.4% | 16.6% | 14.6% | 12.1% | 19.8% | 9.8% | -3.1% | 2.6% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -3.2% | 53.9% | 48.5% | -24.5% | -5.7% | 97.6% | -6.3% | -41.4% | 7.4% | 94.3% | -8.4% | -37.3% | -1.5% | 71.4% | -3.0% | -- |
| OP Growth (YoY) | 55.1% | 42.1% | 306.7% | 15.0% | 0.6% | 17.3% | 15.4% | 17.6% | 33.6% | 11.7% | -53.6% | 6.3% | -- | -- | -- | -- |
| OP Growth (QoQ) | -10.4% | 342.6% | 165.2% | -85.3% | -17.9% | 1166.7% | -25.0% | -87.1% | -4.3% | 1146.2% | -23.5% | -85.3% | -20.0% | 417.9% | 75.0% | -- |
| Profit Growth (YoY) | -- | -6.0% | -643.0% | -257.0% | -13.0% | 14.0% | 2033.0% | 166.0% | 19.0% | -1.0% | -98.0% | -31.0% | -11.0% | 14.0% | -16.0% | -60.0% |
| EPS Growth (YoY) | -7.0% | -5.7% | -725.0% | -351.5% | -13.4% | 14.4% | 1900.0% | 247.4% | 33.7% | 3.3% | -98.4% | -29.6% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -26.5% | 507.2% | 24.7% | -141.3% | -25.6% | 2600.0% | -69.7% | -85.8% | -1.7% | 47100.0% | -94.7% | -94.5% | -24.1% | 637.1% | 129.6% | -- |
| OP Margin | 16.8% | 18.2% | 6.3% | 3.5% | 18.1% | 20.8% | 3.3% | 4.1% | 18.4% | 20.7% | 3.2% | 3.9% | 16.5% | 20.3% | 6.7% | 3.7% |
| Net Margin | 8.3% | 10.9% | -4.2% | -8.2% | 14.9% | 18.8% | 1.3% | 4.3% | 17.6% | 19.2% | 0.0% | 1.4% | 15.7% | 20.3% | 4.8% | 1.9% |
| Material Cost % | -- | 35.0% | 36.6% | 47.1% | 45.0% | 45.1% | 51.0% | 52.2% | 44.4% | 45.4% | 51.9% | 54.8% | 47.4% | 49.2% | 56.0% | 56.8% |
| Employee Cost % | -- | 7.0% | 7.7% | 10.2% | 7.9% | 8.0% | 11.3% | 10.6% | 7.1% | 6.8% | 11.0% | 11.0% | 6.7% | 6.1% | 8.4% | 10.2% |
| P/S | 3.44 | 4.50 | 4.71 | 4.24 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 82.91 | 90.30 | 77.14 | 48.35 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 2.68 | 3.06 | 2.80 | 2.15 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Credit rating assigned by Care Ratings Limited
Transcript of the Earnings Conference call held on August 4, 2026
Schedule of Analyst / Institutional Investors' Conference to be held on August 14, 2026
ESG rating received from Crisil
Unaudited financial results for the quarter ended on June 30, 2026
Outcome of Board Meeting
Voting Results
Proceedings of 32nd AGM
Scrutinizer''s Report
Zydus Wellness Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve unaudited financial results ....
Newspaper publication regarding 32nd Annual General Meeting of the Company
Receipt of Tax Order from Tax Authority by step down subsidiary
Integrated Annual Report for FY 2025-26
Notice of 32nd AGM scheduled on August 4, 2026
BRSR for FY 2025-26
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
Newspaper Publication related to AGM
Change in Senior Management
Incorporation of step-down wholly owned subsidiary in UAE
Appointment of Dr. Shyam Ramakrishnan as Chief Scientific Officer forming part of Senior Management
Intimation of Trading Window Closure for the quarter ending on June 30, 2026
Incorporation of step-down wholly owned subsidiary in UAE
Incorporation of step-down wholly owned subsidiary in Ireland
Analyst / Institutional Investors' Conference on June 25, 2026
Disclosure under SEBI (PIT) Regulations, 2015
Disclosure under SEBI (PIT) Regulations, 2015
Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015
Analyst/ Institutional Investors'' Conference on June 8, 2026
Disclosure under Insider Trading Regulations
Newspaper publication regarding opening of special window for re-lodgement of transfer requests
Disclosure under SEBI (PIT) Regulations, 2015
Transcript of the Earnings conference call held on May 18, 2026
Newspaper publication regarding audited financial results for the quarter and year ended on March 31, 2026
Intimation of record date
Outcome of Board Meeting
Audited financial results for the quarter / year ended on March 31, 2026
Outcome of Board Meeting
Investor Presentation
Prese Release
Change in Director
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026
Audio recording of the Investor Call on audited financial results for the quarter and financial year ended on March 31, 2026
Schedule of Analyst / Institutional Investors' call schedule on May 18, 2026
Zydus Wellness Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve audited financial results and ....
Newspaper Publication - Second 100 days Campaign - "Saksham Niveshak"
Certificate under Reg. 74(5) of the SEBI (DP) Regulations, 2018
Clarification on volume movement
The Exchange has sought clarification from Zydus Wellness Ltd on April 07, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited.
Receipt of Order by step down subsidiary from Spanish Tax Authority
Receipt of Order from GST Authority
Annual Reports
16Credit Ratings
6Concalls
43Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025Jul 2025
31 Jul 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022May 2022
31 May 2022May 2022
31 May 2022Feb 2022
28 Feb 2022Oct 2021
31 Oct 2021Aug 2021
31 Aug 2021Aug 2021
31 Aug 2021May 2021
31 May 2021Jan 2021
31 Jan 2021Oct 2020
31 Oct 2020Sep 2020
30 Sept 2020Jul 2020
31 Jul 2020May 2020
31 May 2020Jan 2020
31 Jan 2020Nov 2019
30 Nov 2019Jul 2019
31 Jul 2019May 2019
31 May 2019Feb 2019
28 Feb 2019Oct 2018
31 Oct 2018Jul 2018
31 Jul 2018May 2018
31 May 2018Jan 2018
31 Jan 2018Nov 2017
30 Nov 2017Feb 2017
28 Feb 2017Nov 2016
30 Nov 2016Jul 2016
31 Jul 2016Jun 2016
30 Jun 2016Held by Mutual Funds
31 schemes hold ZYDUSWELL · sorted by weight